Aberrations of TACC1 and TACC3 are associated with ovarian cancer

BMC Women's Health

Volumn 5, Issue , 2005, Pages

  Lauffart, Brenda ^a   Vaughan, Mary M ^a   Eddy, Roger ^a   Chervinsky, David ^a   DiCioccio, Richard A ^a   Black, Jennifer D ^a   Still, Ivan H ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; REGULATOR PROTEIN; TRANSFORMING ACIDIC COILED COIL 1; TRANSFORMING ACIDIC COILED COIL 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER REGISTRY; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; FAMILIAL DISEASE; FEMALE; FISHER EXACT TEST; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUCINOUS CARCINOMA; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PAPILLARY CARCINOMA; SCORING SYSTEM; SEQUENCE ANALYSIS; SERIAL ANALYSIS OF GENE EXPRESSION;

EID: 26844541629     PISSN: 14726874     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-5-8     Document Type: Article

References (55)

1. Gayther, S. A., Russell, P., Harrington, P., Antoniou, A. C., Easton, D. F., and Ponder, B. A. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am.J.Hum.Genet. 65(4), 1021-1029. 1999.
2. Werness, B. A., Ramus, S. J., Dicioccio, R. A., Whittemore, A. S., Garlinghouse-Jones, K., Oakley-Girvan, I., Tsukada, Y., Harrington, P., Gayther, S. A., Ponder, B.A., and Piver, M. S. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int.J.Gynecol.Pathol. 23(1), 29-34. 2004.
3. Rao, P. H., Harris, C. P., Yan, Lu, X, Li, X. N., Mok, S. C., and Lau, C. C. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes.Cancer 33(2), 123-132. 2002.
4. Suzuki, S., Moore, D. H., Ginzinger, D. G., Godfrey, T. E., Barclay, J., Powell, B., Pinkel, D., Zaloudek, C., Lu, K., Mills, G., Berchuck, A., and Gray, J. W. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 60(19), 5382-5385. 10-1-2000.
5. Ramus, S. J., Pharoah, P. D., Harrington, P., Pye, C., Werness, B., Bobrow, L., Ayhan, A., Wells, D., Fishman, A., Gore, M., Dicioccio, R. A., Piver, M. S., Whittemore, A. S., Ponder, B. A., and Gayther, S. A. BRCA1/2 Mutation Status Influences Somatic Genetic Progression in Inherited and Sporadic Epithelial Ovarian Cancer Cases. Cancer Res. 63(2), 417-423. 1-15-2003.
6. Gene Expression Omnibus repository. http://www.ncbi.nlm.nih.gov/SAGE/.
7. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. Serial analysis of gene expression. Science 270(5235), 484-487. 10-20-1995.
8. SAGE Tag to Gene Mapping Retrieve by SAGE tag: ACTCAATAAA. http://www.ncbi.nlm.nih.gov/SAGE/index.cgi?cmd= tagsearch&org=Hs&tag=ACTCAA TAAA&anchor=NLAIII.
9. SAGE Tag to Gene Mapping Retrieve by SAGE tag: TTTCATTGCC. http://www.ncbi.nlm.nih.gov/sage/index.cgi?&anchor= NLAIII&cmd=tagsearch&tag=TTTCATTGCC&org=Hs
10. Still, I. H., Hamilton, M., Vince, P., Wolfman, A., and Cowell, J. K. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon. Oncogene 18(27), 4032-4038. 7-8-1999.
11. Still, I. H., Vince, P., and Cowell, J. K. The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines. Genomics 58(2), 165-170. 6-1-1999.
12. National Cancer Institute, Center for Cancer ResearchTechnology Initiatives, Tissue Array Research Program (TARP). http://ccr.cancer.gov/tech_initiatives/tarp/default.asp.
13. Shimizu, Y., Kamoi, S., Amada, S., Akiyama, F., and Silverberg, S. G. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 82(5), 893-901. 3-1-1998.
14. Morgan, R. Jnr, Alvares, R. R., Armstrong, D. K., Copeland, L., Fiorica, J, Fishman, D. D., Fowler, J., Gershenson, D., Greer, B. E., Johnston, C., Kessinger, A., Lele, S., Locker, G. Y., Matulonis, V., Ozols, R. F., Sabbatini, P., and Teng, N. NCCN Practice guidelines for ovarian cancer. National Comprehensive Cancer Network, Complete library of NCCN Oncology Practice Guidelines. 2000.
15. Kuklin, A., Munson, K., Gjerde, D., Haefele, R., and Taylor, P. Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. Genet.Test. 1(3), 201-206. 1997.
16. dbSNP Homepage. http://www.ncbi.nlm.nih.gov/SNP/index.html.
17. Aitola, M., Sadek, C. M., Gustafsson, J. A., and Pelto-Huikko, M. Aint/Tacc3 is highly expressed in proliferating mouse tissues during development, spermatogenesis, and oogenesis. J.Histochem.Cytochem. 51(4), 455-469. 2003.
18. Sadek, C. M., Jalaguier, S., Feeney, E. P., Aitola, M., Damdimopoulos, A. E., Pelto-Huikko, M., and Gustafsson, J. Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development. Mech.Dev. 97(1-2), 13-26. 2000.
19. Sadek, C. M., Pelto-Huikko, M., Tujague, M., Steffensen, K. R., Wennerholm, M., and Gustafsson, J. A. TACC3 expression is tightly regulated during early differentiation. Gene Expr.Patterns. 3(2), 203-211. 2003.
20. Capo-chichi, C. D., Roland, I. H., Vanderveer, L., Bao, R., Yamagata, T., Hirai, H., Cohen, C., Hamilton, T. C., Godwin, A. K., and Xu, X. X. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer Res. 63(16), 4967-4977. 8-15-2003.
21. McKeveney, P. J., Hodges, V. M., Mullan, R. N., Maxwell, P., Simpson, D., Thompson, A., Winter, P. C., Lappin, T. R., and Maxwell, A. P. Characterization and localization of expression of an erythropoietin- induced gene, ERIC-1/TACC3, identified in erythroid precursor cells. Br.J.Haematol. 112(4), 1016-1024. 2001.
22. Climent, J., Martinez-Climent, J. A., Blesa, D., Garcia-Barchino, M. J., Saez, R., Sanchez-Izquierdo, D., Azagra, P., Lluch, A., and Garcia-Conde, J. Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer. Clin.Cancer Res. 8(12), 3863-3869. 2002.
23. Forozan, F., Mahlamaki, E. H., Monni, O., Chen, Y., Veldman, R., Jiang, Y., Gooden, G. C., Ethier, S. P., Kallioniemi, A., and Kallioniemi, O. P. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 60(16), 4519-4525. 8-15-2000.
24. Wang, Z. C., Lin, M., Wei, L. J., Li, C., Miron, A., Lodeiro, G., Harris, L., Ramaswamy, S., Tanenbaum, D. M., Meyerson, M., Iglehart, J. D., and Richardson, A Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers. Cancer Res. 64(1), 64-71. 1-1-2004.
25. Sherwood, J. B., Shivapurkar, N., Lin, W. M., Ashfaq, R., Miller, D. S., Gazdar, A. F., and Muller, C. Y. Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants. Gynecol.Oncol. 79(1), 90-96. 2000.
26. Nagase, S., Sato, S., Tezuka, F., Wada, Y., Yajima, A., and Horii, A. Deletion mapping on chromosome 10q25-q26 in human endometrial cancer. Br.J.Cancer 74(12), 1979-1983. 1996.
27. Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., and Nakamura, Y. Allelotype of human ovarian cancer. Cancer Res. 51(19), 5118-5122. 10-1-1991.
28. Conte, N., Charafe-Jauffret, E., Delaval, B., Adelaide, J., Ginestier, C., Geneix, J., Isnardon, D., Jacquemier, J., and Birnbaum, D. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators. Oncogene 21(36), 5619-5630. 8-15-2002.
29. Ma, X. J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., Zhou, Y. X., Varnholt, H., Smith, B., Gadd, M., Chatfield, E., Kessler, J., Baer, T. M., Erlander, M. G., and Sgroi, D. C. Gene expression profiles of human breast cancer progression. Proc.Natl.Acad.Sci.U.S.A 100(10), 5974-5979. 5-13-2003.
30. Jacquemier, J., Ginestier, C., Rougemont, J., Bardou, V. J., Charafe-Jauffret, E., Geneix, J., Adelaide, J., Koki, A., Houvenaeghel, G., Hassoun, J., Maraninchi, D., Viens, P., Birnbaum, D., and Bertucci, F. Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res. 65(3), 767-779. 2-1-2005.
31. Rhodes, D. R., Barrette, T. R., Rubin, M. A., Ghosh, D., and Chinnaiyan, A. M. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 62(15), 4427-4433. 8-1-2002.
32. Line, A., Slucka, Z., Stengrevics, A., Li, G., and Rees, R. C. Altered splicing pattern of TACC1 mRNA in gastric cancer. Cancer Genet.Cytogenet. 139(1), 78-83. 2002.
33. Adelaide, J., Chaffanet, M., Imbert, A., Allione, F., Geneix, J., Popovici, C., van Alewijk, D., Trapman, J., Zeillinger, R., Borresen-Dale, A. L., Lidereau, R., Birnbaum, D., and Pebusque, M. J. Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes.Cancer 22(3), 186-199. 1998.
34. Pan, Y., Lui, W. O., Nupponen, N., Larsson, C., Isola, J., Visakorpi, T., Bergerheim, U. S., and Kytola, S. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines. Genes Chromosomes.Cancer 30(2), 187-195. 2001.
35. Theillet, C., Adelaide, J., Louason, G., Bonnet-Dorion, F., Jacquemier, J., Adnane, J., Longy, M., Katsaros, D., Sismondi, P., and Gaudray, P. FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes.Cancer 7(4), 219-226. 1993.
36. Lauffart, B., Gangisetty, O., and Still, I. H. Molecular cloning, genomic structure and interactions of the putative breast tumor suppressor TACC2. Genomics 81(2), 192-201. 2003.
37. Thai, T. H., Du, F., Tsan, J. T., Jin, Y., Phung, A., Spillman, M. A., Massa, H. F., Muller, C. Y., Ashfaq, R., Mathis, J. M., Miller, D. S., Trask, B. J., Baer, R., and Bowcock, A. M. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum.Mol.Genet. 7(2), 195-202. 1998.
38. Karppinen, S. M., Heikkinen, K., Rapakko, K., and Winqvist, R. Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J.Med.Genet. 41(9), e114. 2004.
39. Ishitobi, M., Miyoshi, Y., Hasegawa, S., Egawa, C., Tamaki, Y., Monden, M., and Noguchi, S. Mutational analysis of BARD1 in familial breast cancer patients in Japan. Cancer Lett. 200(1), 1-7. 10-8-2003.
40. Jishi, M. F., Itnyre, J. H., Oakley-Girvan, I. A., Piver, M. S., and Whittemore, A. S. Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry. Cancer 76(8), 1416-1421. 10-15-1995.
41. Kerber, R. A. and Slattery, M. L. The impact of family history on ovarian cancer risk. The Utah Population Database. Arch.Intern.Med. 155(9), 905-912. 5-8-1995.
42. Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K., and Leung, P. C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr.Rev. 22(2), 255-288. 2001.
43. Paley, P. J., Swisher, E. M., Garcia, R. L., Agoff, S. N., Greer, B. E., Peters, K. L., and Goff, B. A. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol.Oncol. 80(2), 176-180. 2001.
44. Agoff, S. N., Mendelin, J. E., Grieco, V. S., and Garcia, R. L. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up. Am.J.Surg.Pathol. 26(2), 171-178. 2002.
45. Boulton, S. J., Martin, J. S., Polanowska, J., Hill, D. E., Gartner, A., and Vidal, M. BRCA1/BARD1 Orthologs Required for DNA Repair in Caenorhabditis elegans. Curr.Biol. 14(1), 33-39. 1-6-2004.
46. Stewart, J. P., Thompson, A., Santra, M., Barlogie, B., Lappin, T. R., and Shaughnessy, J., Jr. Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma. Br.J.Haematol. 126(1), 72-76. 2004.
47. Hemminki, K. and Granstrom, C. Familial clustering of ovarian and endometrial cancers. Eur.J.Cancer 40(1), 90-95. 2004.
48. Stratton, J. F., Thompson, D., Bobrow, L., Dalal, N., Gore, M., Bishop, D. T., Scott, I., Evans, G., Daly, P., Easton, D. F., and Ponder, B. A. The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am.J.Hum.Genet. 65(6), 1725-1732. 1999.
49. Chen, H. M., Schmeichel, K. L., Mian, I. S., Lelievre, S., Petersen, O. W., and Bissell, M. J. AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression. Mol.Biol.Cell 11(4), 1357-1367. 2000.
50. Gard, D. L., Becker, B. E., and Josh, Romney S. MAPping the eukaryotic tree of life: structure, function, and evolution of the MAP215/Dis1 family of microtubule-associated proteins. Int.Rev.Cytol. 239, 179-272. 2004.
51. Still, I. H., Vettaikkorumakankauv, A. K., DiMatteo, A., and Liang, P. Structure-function evolution of the transforming acidic coiled coil genes revealed by analysis of phylogenetically diverse organisms. BMC.Evol.Biol. 4(1), 16. 6-18-2004.
52. Piekorz, R. P., Hoffmeyer, A., Duntsch, C. D., McKay, C., Nakajima, H., Sexl, V., Snyder, L., Rehg, J., and Ihle, J. N. The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis. EMBO J. 21(4), 653-664. 2-15-2002.
53. Gergely, F., Karlsson, C., Still, I., Cowell, J., Kilmartin, J., and Raff, J. W. The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc.Natl.Acad.Sci.U.S.A 97(26), 14352-14357. 12-19-2000.
54. Garriga-Canut, M. and Orkin, S. H. Transforming acidic coiled-coil protein 3 (TACC3) controls friend of GATA-1 (FOG-1) subcellular localization and regulates the association between GATA-1 and FOG-1 during hematopoiesis. J.Biol.Chem. 279(22), 23597-23605. 5-28-2004.
55. Gangisetty, O., Lauffart, B., Sondarva, G. V., Chelsea, D. M., and Still, I. H. The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. Oncogene 23(14), 2559-2563. 4-1-2004.